These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7066741)

  • 21. Malignant hyperthermia: effects of halothane on the surface membrane.
    Iaizzo PA; Lehmann-Horn F; Taylor SR; Gallant EM
    Muscle Nerve; 1989 Mar; 12(3):178-83. PubMed ID: 2725547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
    Sullivan JS; Denborough MA
    Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
    Ellis FR; Halsall PJ; Hopkins PM
    Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
    Ranklev E; Fletcher R; Blomquist S
    Br J Anaesth; 1986 Jun; 58(6):646-8. PubMed ID: 3707802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane.
    Snoeck MM; Gielen MJ; Tangerman A; van Egmond J; Dirksen R
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):334-7. PubMed ID: 10714850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma.
    Nelson TE; Flewellen EH; Gloyna DF
    Anesth Analg; 1983 Jun; 62(6):545-52. PubMed ID: 6846875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine malignant hyperthermia: halothane effects on force generation in skeletal muscles.
    Gallant EM; Goettl VM
    Muscle Nerve; 1989 Jan; 12(1):56-63. PubMed ID: 2747737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
    Bendixen D; Ording H
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
    Williams JH; Lee JC; Holland M
    Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
    Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
    Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age, fiber type composition and in vitro contracture responses in human malignant hyperthermia.
    Ording H; Hansen U; Skovgaard LT
    Acta Anaesthesiol Scand; 1988 Feb; 32(2):121-4. PubMed ID: 3348072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ].
    López JR; Contreras J; Linares N; Allen PD
    Anesthesiology; 2000 Jun; 92(6):1799-806. PubMed ID: 10839932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
    Gallant EM; Fletcher TF; Goettl VM; Rempel WE
    Muscle Nerve; 1986 Feb; 9(2):174-84. PubMed ID: 3951491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of calcium ions for in vitro malignant hyperthermia testing.
    Fletcher JE; Huggins FJ; Rosenberg H
    Can J Anaesth; 1990 Sep; 37(6):695-8. PubMed ID: 2208545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of the ionophore A23187 on the mechanical responses of muscle in normal Pietrain pigs and pigs with malignant hyperthermia.
    Reiss G; Monin G; Lauer C
    Can J Physiol Pharmacol; 1986 Mar; 64(3):248-53. PubMed ID: 3085909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.